MeSH term
Frequency | Condition_Probility | Animals | 21 | 0.0 |
Cell Line | 13 | 0.0 |
Cells, Cultured | 4 | 0.0 |
*DNA Damage | 3 | 0.0 |
*DNA-Binding Proteins | 27 | 1.0 |
Dose-Response Relationship, Radiation | 3 | 0.0 |
Humans | 59 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Mice | 12 | 0.0 |
Mice, Knockout | 5 | 0.0 |
Models, Biological | 8 | 0.0 |
Mutation | 13 | 0.0 |
Proteins/genetics/physiology | 2 | 3.0 |
Research Support, Non-U.S. Gov't | 45 | 0.0 |
Apoptosis | 6 | 0.0 |
*Cell Cycle Proteins | 24 | 1.0 |
DNA Damage | 6 | 0.0 |
DNA Repair | 7 | 1.0 |
*Nuclear Proteins | 15 | 0.0 |
Oxidative Stress | 2 | 0.0 |
Oxygen/metabolism | 3 | 1.0 |
Protein Binding | 13 | 0.0 |
Proteins/genetics | 4 | 0.0 |
BRCA1 Protein/metabolism | 2 | 5.0 |
Female | 12 | 0.0 |
Male | 15 | 0.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Proteins/metabolism | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 26 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Fanconi Anemia/*genetics/*metabolism | 2 | 40.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Genetic Complementation Test | 15 | 2.0 |
Phosphorylation | 5 | 0.0 |
Precipitin Tests | 10 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Adolescent | 5 | 0.0 |
Adult | 5 | 0.0 |
Child | 6 | 0.0 |
Child, Preschool | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Fanconi Anemia/*genetics | 16 | 34.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Gamma Rays | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Mitomycin/pharmacology | 11 | 11.0 |
Mutation/*genetics | 2 | 0.0 |
Ultraviolet Rays | 3 | 0.0 |
Comparative Study | 5 | 0.0 |
DNA Primers | 3 | 0.0 |
Fanconi Anemia/*genetics/physiopathology | 2 | 66.0 |
Flow Cytometry | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Blotting, Western | 7 | 0.0 |
Cell Line, Transformed | 4 | 0.0 |
Fanconi Anemia/*enzymology | 2 | 100.0 |
Proteins/*metabolism | 4 | 0.0 |
Transfection | 7 | 0.0 |
Cell Nucleus/metabolism | 7 | 0.0 |
Gene Expression | 3 | 0.0 |
Hela Cells | 6 | 0.0 |
Immunoblotting | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Proteins/genetics/*metabolism | 4 | 0.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Two-Hybrid System Techniques | 6 | 0.0 |
DNA Repair/*genetics | 2 | 0.0 |
Genetic Heterogeneity | 2 | 0.0 |
Genotype | 5 | 0.0 |
Cell Cycle | 4 | 0.0 |
English Abstract | 3 | 0.0 |
Base Sequence | 6 | 0.0 |
Haplotypes | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Fanconi Anemia/*metabolism | 5 | 41.0 |
Mitosis | 2 | 0.0 |
Nuclear Proteins/analysis | 2 | 1.0 |
Proteins/*analysis | 2 | 1.0 |
Cell Survival | 2 | 0.0 |
Fanconi Anemia/*genetics/metabolism | 3 | 37.0 |
Macromolecular Substances | 3 | 0.0 |
Exons | 5 | 0.0 |
Homozygote | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Mutagenesis | 4 | 0.0 |
Nucleic Acid Synthesis Inhibitors/pharmacology | 2 | 1.0 |
Protein Structure, Tertiary | 6 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
*Mutation | 6 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Infant | 2 | 0.0 |
Phenotype | 8 | 0.0 |
Proteins/*genetics | 4 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Fanconi Anemia/genetics/*metabolism | 2 | 50.0 |
Cell Nucleus/*metabolism | 3 | 0.0 |
Kinetics | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Nuclear Localization Signal | 2 | 2.0 |
Binding Sites/genetics | 4 | 0.0 |
COS Cells | 3 | 0.0 |
Plasmids | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Proteins/*genetics/metabolism | 3 | 1.0 |
Genes, Recessive | 3 | 0.0 |
Proteins/genetics/*physiology | 2 | 1.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Proteins/chemistry/*genetics | 2 | 1.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
In Vitro | 2 | 0.0 |
*Protein Biosynthesis | 2 | 0.0 |
Fibroblasts | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Amino Acid Substitution/genetics | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Introns | 3 | 0.0 |
Models, Genetic | 3 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Nuclear Proteins/genetics | 3 | 1.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
*Oxidative Stress | 2 | 0.0 |
Cross-Linking Reagents/pharmacology | 4 | 2.0 |
Middle Aged | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Time Factors | 3 | 0.0 |
*Genes, BRCA2 | 2 | 0.0 |
Jews/*genetics | 2 | 1.0 |
Aged | 2 | 0.0 |
Fanconi Anemia/*genetics/metabolism/pathology | 2 | 66.0 |
Genes, BRCA1 | 2 | 1.0 |
Disease Models, Animal | 3 | 0.0 |
